118 related articles for article (PubMed ID: 9288168)
21. Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist.
Nishikibe M; Ohta H; Okada M; Ishikawa K; Hayama T; Fukuroda T; Noguchi K; Saito M; Kanoh T; Ozaki S; Kamei T; Hara K; William D; Kivlighn S; Krause S; Gabel R; Zingaro G; Nolan N; O'Brien J; Clayton F; Lynch J; Pettibone D; Siegl P
J Pharmacol Exp Ther; 1999 Jun; 289(3):1262-70. PubMed ID: 10336515
[TBL] [Abstract][Full Text] [Related]
22. BAY X1005, a new selective inhibitor of leukotriene synthesis: pharmacology and pharmacokinetics.
Müller-Peddinghaus R; Fruchtmann R; Ahr HJ; Beckermann B; Bühner K; Fugmann B; Junge B; Matzke M; Kohlsdorfer C; Raddatz S
J Lipid Mediat; 1993; 6(1-3):245-8. PubMed ID: 8395246
[TBL] [Abstract][Full Text] [Related]
23. Role of 5-lipoxygenase products in the local accumulation of neutrophils in dermal inflammation in the rabbit.
Marleau S; Fruteau de Laclos B; Sanchez AB; Poubelle PE; Borgeat P
J Immunol; 1999 Sep; 163(6):3449-58. PubMed ID: 10477617
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of pyrimido[4,5-b][1,4]benzothiazine derivatives, as potent 15-lipoxygenase inhibitors.
Bakavoli M; Nikpour M; Rahimizadeh M; Saberi MR; Sadeghian H
Bioorg Med Chem; 2007 Mar; 15(5):2120-6. PubMed ID: 17210254
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
Rao PN; Chen QH; Knaus EE
J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
[TBL] [Abstract][Full Text] [Related]
27. Substituted chromenes as potent, orally active 5-lipoxygenase inhibitors.
Satoh Y; Stanton JL; Hutchison AJ; Libby AH; Kowalski TJ; Lee WH; White DH; Kimble EF
J Med Chem; 1993 Nov; 36(23):3580-94. PubMed ID: 8246226
[TBL] [Abstract][Full Text] [Related]
28. The effect of a novel, dual function histamine H1 receptor antagonist/5-lipoxygenase enzyme inhibitor on in vivo dermal inflammation and extravasation.
Giannaras A; Selig W; Ellis J; Hullinger T
Eur J Pharmacol; 2005 Jan; 506(3):265-71. PubMed ID: 15627437
[TBL] [Abstract][Full Text] [Related]
29. [Inhibition of the arachidonic acid cascade by aza-2-aryl-1,4-naphthoquinone derivatives].
Richwien A; Wurm G
Pharmazie; 2004 Dec; 59(12):906-12. PubMed ID: 15638076
[TBL] [Abstract][Full Text] [Related]
30. Potent and selective 5-LO inhibitor bearing benzothiophene pharmacophore: discovery of MK-5286.
Li L; Berthelette C; Chateauneuf A; Ouellet M; Sturino CF; Wang Z
Bioorg Med Chem Lett; 2010 Dec; 20(24):7440-3. PubMed ID: 21044840
[TBL] [Abstract][Full Text] [Related]
31. Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitors.
Crawley GC; Dowell RI; Edwards PN; Foster SJ; McMillan RM; Walker ER; Waterson D; Bird TG; Bruneau P; Giroaeau JM
J Med Chem; 1992 Jul; 35(14):2600-9. PubMed ID: 1321908
[TBL] [Abstract][Full Text] [Related]
32. SAR-study on a new class of imidazo[1,2-a]pyridine-based inhibitors of 5-lipoxygenase.
Hieke M; Rödl CB; Wisniewska JM; la Buscató E; Stark H; Schubert-Zsilavecz M; Steinhilber D; Hofmann B; Proschak E
Bioorg Med Chem Lett; 2012 Mar; 22(5):1969-75. PubMed ID: 22326163
[TBL] [Abstract][Full Text] [Related]
33. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation.
Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Aramori I; Hatori C; Sawai H; Oku T; Tanaka H
J Med Chem; 1998 Nov; 41(23):4587-98. PubMed ID: 9804698
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of celecoxib analogues possessing a N-difluoromethyl-1,2-dihydropyrid-2-one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
J Med Chem; 2009 Mar; 52(6):1525-9. PubMed ID: 19296694
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of a class of 5-benzylidene-2-phenyl-thiazolinones as potent 5-lipoxygenase inhibitors.
Barzen S; Rödl CB; Lill A; Steinhilber D; Stark H; Hofmann B
Bioorg Med Chem; 2012 Jun; 20(11):3575-83. PubMed ID: 22551629
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
Farmaco; 2005 Apr; 60(4):327-32. PubMed ID: 15848208
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of 1-(benzenesulfonamido)-2-[5-(N-hydroxypyridin-2(1H)-one)]acetylene regioisomers: a novel class of 5-lipoxygenase inhibitors.
Chowdhury MA; Chen H; Abdellatif KR; Dong Y; Petruk KC; Knaus EE
Bioorg Med Chem Lett; 2008 Jul; 18(14):4195-8. PubMed ID: 18541424
[TBL] [Abstract][Full Text] [Related]
38. 5-lipoxygenase inhibitors with histamine H(1) receptor antagonist activity.
Lewis TA; Bayless L; Eckman JB; Ellis JL; Grewal G; Libertine L; Marie Nicolas J; Scannell RT; Wels BF; Wenberg K; Wypij DM
Bioorg Med Chem Lett; 2004 May; 14(9):2265-8. PubMed ID: 15081022
[TBL] [Abstract][Full Text] [Related]
39. Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5-lipoxygenase.
Malamas MS; Carlson RP; Grimes D; Howell R; Glaser K; Gunawan I; Nelson JA; Kanzelberger M; Shah U; Hartman DA
J Med Chem; 1996 Jan; 39(1):237-45. PubMed ID: 8568813
[TBL] [Abstract][Full Text] [Related]
40. Structure-based design and synthesis of non-nucleoside, potent, and orally bioavailable adenosine deaminase inhibitors.
Terasaka T; Okumura H; Tsuji K; Kato T; Nakanishi I; Kinoshita T; Kato Y; Kuno M; Seki N; Naoe Y; Inoue T; Tanaka K; Nakamura K
J Med Chem; 2004 May; 47(11):2728-31. PubMed ID: 15139750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
